Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early empirical antibiotic prophylaxis after snakebite in the Brazilian Amazon
RBR-3h33wyPhase 4Recruiting
- Sponsor
- Universidade do Estado do Amazonas
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofloxacin in bacterial disease and snakebite envenomation (2 arms), sponsored by Universidade do Estado do Amazonas. Started Jul 2014; status: recruiting.
02
Drugs
ciprofloxacin
03
Conditions
bacterial diseasesnakebite envenomation
Beyond the preview
Go deeper on RBR-3h33wy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3h33wy.